Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

Slides:



Advertisements
Similar presentations
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB   Martin J. Edelman, MD, Lydia.
Advertisements

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer  Wu-Wei Lai, MD, Fen-Fen Chen, MD,
Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer  Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Volume 52, Issue 3, Pages (September 2007)
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD 
Didier Lardinois, MD, Renate Rechsteiner, MD, R
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer  Dage Liu, MD, Cheng-long Huang, MD, Kotaro.
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
Joshua E. Rosen, BASc, Hari B
Clinicopathological and biological assessment of lung cancers with pleural dissemination  Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Tumor marker expression is predictive of survival in patients with esophageal cancer  Thomas A Aloia, MD, David H Harpole, MD, Carolyn E Reed, MD, Carmen.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
Histologic Evolution From Adenocarcinoma to Squamous Cell Carcinoma After Gefitinib Treatment  Min-Shu Hsieh, MD, Jie-Yang Jhuang, MD, Syue-Fong Hua,
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Survival after resection of synchronous non–small cell lung cancer
Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer  Franz Blaes, MD, Markus Klotz, Hanno Huwer, MD, Uwe.
Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer  Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD,
David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L
Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma  Masahiro Yasunaga,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival  Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,
Deregulated p21WAF1 Overexpression Impacts Survival of Surgically Resected Esophageal Squamous Cell Carcinoma Patients  Yih-Gang Goan, MD, Hon-Ki Hsu,
Effects of Depletion of Leukocytes and Platelets on Cardiac Dysfunction After Cardiopulmonary Bypass  Yukio Chiba, Kouichi Morioka, Ryusuke Muraoka, Akio.
Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma  Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,
Sex-associated differences in survival of patients undergoing resection for lung cancer  Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 
Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non- small Cell Lung Cancer After Surgery  Xianhua Xu, MD, Ping-Li Sun,
Mariano Garcı́a-Yuste, MD, José M
Lung Cancer Surgery in Patients With Liver Cirrhosis
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Interstitial tumor-associated macrophages combined with tumor-derived colony- stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non–small.
Prognostic factors in clinical stage I non–small cell lung cancer
Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance  Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer  J. Buhr,
Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.
Expression of vascular endothelial growth factor in thoracic sarcomas
Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity  Akira Iyoda, MD, Kenzo Hiroshima, MD, Yasumitsu Moriya, MD, Teruaki.
Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer  Wu-Wei Lai, MD, Fen-Fen Chen, MD,
High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma  Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.
Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung  Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.
Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer  Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.
Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma  kai Wang, MD, Wei Ma, MD, Jianbo Wang, MD, Liang Yu,
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection  Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,
Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma  Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,
Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung  Florian Eichhorn, MD, Hendrik Dienemann, MD,
James D Luketich, Michael E Burt  The Annals of Thoracic Surgery 
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer  Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,
Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma  Kuang-Tai Kuo, MD, Kuan-Chih Chow, PhD, Yu-Chung.
Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer  Bernward Passlick, MD, Boris Kubuschok, MD,
Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker  Adnan Sayar,
Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Mark I. Block, MD  The Annals of Thoracic Surgery 
Presentation transcript:

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke Muraoka, Nobuhiko Tanigawa  The Annals of Thoracic Surgery  Volume 65, Issue 5, Pages 1405-1409 (May 1998) DOI: 10.1016/S0003-4975(97)01416-1

Fig. 1 Immunohistochemical staining by anti-CD34 antibodies in lung cancer (squamous cell carcinoma). (A) Example of a tumor in the hypervascular group, showing a number of small caliber microvessels. (B) Example of a tumor in the hypovascular group. (Original magnification, ×200; scale bar = 100 μm.) The Annals of Thoracic Surgery 1998 65, 1405-1409DOI: (10.1016/S0003-4975(97)01416-1)

Fig. 2 Kaplan-Meier survival curves based on the microvessel counts in tumors of patients with non–small cell lung cancer. Survival time is significantly shorter in patients in the hypervascular group than in the hypovascular group (p < 0.00001). The Annals of Thoracic Surgery 1998 65, 1405-1409DOI: (10.1016/S0003-4975(97)01416-1)